Gilead Sciences Inc. closed 10.06% short of its 52-week high of $119.96, which the company achieved on March 10th.

NORTHAMPTON, MA / ACCESS Newswire / March 25, 2025 / HIV infection and lung cancer have little in common from a disease ...

Board member Mick Hitchcock named interim CEO replacing Thomas Butler.COO and President Ramses Erdtmann continuing at Biomea in current role.REDWOOD CITY, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- ...

Biomea Fusion appointed one of its board members, Mick Hitchcock, to succeed Thomas Butler as its interim chief executive. The change will help to ensure the company realizes its full potential ...

Assembly Biosciences (NASDAQ:ASMB – Get Free Report)‘s stock had its “neutral” rating reiterated by stock analysts at HC ...

Guggenheim initiated coverage on shares of Assembly Biosciences (NASDAQ:ASMB – Free Report) in a report released on Tuesday morning, Marketbeat reports. The brokerage issued a buy rating and a $31.00 ...

Shares of UNITY Biotechnology UBX crashed 28.8% yesterday, following mixed results from a mid-stage non-inferiority study of ...

Shares of Regeneron Pharmaceuticals Inc. slipped 4.06% to $634.14 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.16% to ...

"Dr. Medvec's strategic value to our company is significant,” said Amir Heshmatpour, NeOnc's Executive Chairman. "We anticipate receiving significant benefits from her insights and guidance as NeOnc ...

GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...

Prominent outside scientists who help the NIH evaluate its internal research programs are being abruptly removed ...